Three months ago Everpure delivered the kind of quarter that usually reprices a stock for good: a roughly $500 million lift to its fiscal 2027 revenue outlook, a second top-five hyperscaler design win and record deal sizes. Since then it has also put out a fiscal 2028 revenue target of $7.0 billion to $7.3 billion, well above where analysts had been. Yet the shares have slipped 7.8% since that report, trailing the S&P 500 by more than five points, and they sit far closer to their post-earnings low of $89.65 than to the $157.57 peak reached in the euphoria. When Everpure reports fiscal third-quarter results after the close on November 18, the question is less whether demand is strong and more whether the quality of that growth can carry the stock back toward those highs.
The near-term bar is clear. Analysts expect earnings of $0.77 per share on revenue of $1.33 billion, which sits right at the midpoint of management's $1.325 billion to $1.335 billion guide and implies growth of about 38%. The Earnings Whisper of $0.81 is modestly above consensus, a sign that the market expects a beat but not a blowout. The more telling comparison is annual. Consensus for fiscal 2027 stands at $5.29 billion, comfortably above management's reiterated $5.03 billion to $5.07 billion range. With the third quarter modeled at the midpoint, the Street is effectively betting that management will raise again and that the fourth quarter will absorb most of the upside. Fiscal 2028 runs the other way, with the $6.2 billion consensus sitting below company guidance, so analysts are more aggressive than management on this year and more cautious on next.
That skepticism about the longer view connects directly to the caveats from last quarter. Growth is being driven by price, mix and capacity rather than unit volume, which actually fell year over year as customers bought fewer systems at higher prices amid NAND cost inflation not seen since 2017. Product gross margin improved to 66.2%, but management signaled it is operating near the low end of its 65% to 70% range. Holding or expanding that figure while input costs climb would show pricing power is real. A slip back toward 65%, or a further drop in units, would raise the uncomfortable possibility that today's revenue is partly borrowed from inflated prices that could normalize.
Cash flow is the other pressure point. Free cash flow swung to negative $238 million last quarter as Everpure stockpiled components, and cash fell to about $1 billion. Management still guides $600 million to $800 million in full-year free cash flow, which requires a sharp back-half reversal. Evidence that those pre-bought parts are converting into shipped product and collected cash would ease inventory-risk worries; another quarter of heavy outflow would make the annual target look stretched.
On the growth side, the indicators that validated the breakout narrative need to hold. Remaining performance obligations topped $4 billion last quarter, growing 44%, and Evergreen One contract value reached an annualized run rate above $1 billion. International revenue jumped 75% to a record 42% of sales, a mix that may prove lumpy if large deals slipped. The second hyperscaler contributes little revenue this year, and with hyperscale results now reported as a combined category, investors will have to read the ramp through commentary on order timelines extending into calendar 2028.
Sentiment has cooled considerably, with bullish readings falling from 48% to about 22%, even as the stock holds above its 200-day moving average near $95. That leaves room for a positive surprise, but the decisive issue is straightforward: Everpure needs to show that its pricing-led acceleration produces durable margins and real cash, not just bigger invoices, if the fiscal 2028 vision is to win back the market's confidence.